🚀 A new era in pancreatic cancer research is taking shape! 🇪🇺 €10M in EU Horizon Europe funding for @PALACROSeu 26 centers across 12 countries joining forces to improve treatment for LAPC The future is changing. And we’re thrilled to help shape it! 💪

Pancreatic cancer in Italy 🇮🇹 in 2035 Check out our new paper 📄 in @UpdatesSurgery and help us taking urgent 🚨 action! rdcu.be/rbMXdkKkGRBa

🇮🇹 Pancreatic cancer in Italy: what will 2035 look like? 📈 >13% increase in deaths 👴 Driven largely by population aging ⚠️ But with a striking North–South divide in mortality trends. 👉Forecasting disease burden is healthcare planning👈 link.springer.com/article/10…

🔴🔴During the past few days we had the enormous pleasure to host the first surgical residents led conference, dedicated to other residents and medicine students 🏆 ResidentX! 🎓 Together with guests 🇺🇸 like @cwolfga2 we warmly welcome the 32 new residents in general surgery!

😨 If you do pancreas surgery you do FEAR chronic corticosteroid therapies… 🇮🇹🇺🇸🇳🇱🇯🇵 2.5k patients matched per therapy 💊Chronic steroids led to ⬆️ morbidity, mortality (10%!) and infections 🔴 Risk stratification should be balanced accordingly! sciencedirect.com/science/ar…

Great collaboration with @CUpancreas 🇮🇹 🇺🇸🎓🎓🎓

Pancreatic cancer surgery in Italy 🇮🇹outcomes by hospital volume 🏥 3.4k surgeries / 90day mortality 10% 🔴 <30 surg - mortality > 10% = 21% 🟡 30-50 surg - mortality >5% = 18% 🟢 >50 surg - mortality <5% = 61% 📣 Pancreas unit urgently needed 📣 link.springer.com/article/10…

Personalised decision-making in hepatocellular carcinoma: conceptual evolution over two decades ➡️doi.org/10.1093/bjsopen/zrag… Evidence-based medicine was conceived to integrate best available evidence, clinical expertise, and patient values, yet in many fields it has come to be equated with rigid guideline algorithms. This narrative, conceptual review draws selectively on landmark staging frameworks, guidelines, and methodological literature to trace two decades of decision-making in hepatocellular carcinoma across a sequence of schematic frames: stage-centred algorithms, recognition of differential treatment effects, multiparametric expert deliberation, and dynamic, time-dependent bidirectional strategies reinforced by immune checkpoint inhibitor combinations. The trajectory culminates in explicit acknowledgement of irreducible uncertainty, with the multiparametric therapeutic hierarchy positioned at the interface between baseline and treatment-conditioned prognosis and aligned with GRADE evidence-to-decision principles. The authors conclude that hepatocellular carcinoma exemplifies personalised decision-making in complex multidisciplinary care, where transparency about what is known, what is uncertain, and where value judgements enter is preferable to further algorithmic refinement. 👏👏👏@Vaital73, Gordon Guyatt, Masatoshi Kudo, Laura Kulik, David J Pinato, Laura Crocetti, Edoardo G Giannini, @prof_cillo #SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery #HPBSurgery #LiverSurgery #HCC #SurgicalOncology #EvidenceBasedSurgery

Uncertainty in medicine isn't a flaw to engineer away with finer algorithms. It's intrinsic to every individual decision. Our new paper in BJS Open traces 20 years of liver cancer to make the case. Honoured to have Gordon Guyatt as co-author. doi.org/10.1093/bjsopen/zrag…

🍒 Small p-NET <2cm always a challenge 🇮🇹 🇯🇵 🇫🇷 🇹🇷 🇬🇧 🇩🇪 460 resected / 35% enucleation ⚠️ Central panc morbidity 25% 🆚 enucleation 10% and ⬆️ POPF / LOS 🫐 LN Mets 14% 🙃 My take: less (no surgery) is MORE! onlinelibrary.wiley.com/doi/…

Of surgical dogma and lemonade 🍋 managing the drain left after pancreatoduodenectomy ✍️ Beautiful commentary by @HalletJulie in @BjsOpen a pleasure to read! ↓↓↓ academic.oup.com/bjsopen/art…

Honored to represent @EurPancClub at the 53 Japan Pancreas Society 🇪🇺🤝🇯🇵 in Fukuoka ✋ STOP surveillance in IPMN was a hot topic 🔥 but controversial 💰 Current policies not cost effective but concomitant PDAC is a big issue in long run … more evidence needed!

Thank you @BjsOpen 🟢🟢@BJSAcademy for featuring our paper Great collaboration 🇮🇹🇳🇱🇩🇪 with @surgery_hps @amsterdamumc and strong work by junior PIs✌️

🇮🇹 LITALHICA proposes a new approach to LT for unresectable #PerihilarCCA: replacing Mayo chemoradiotherapy with modern systemic therapy for biological selection. A promising step in #TransplantOncology. 👏 ovid.com/10.1097/TP.00000000…

🚨 From Clinical Heterogeneity to National Standardization in Liver Transplantation for Perihilar Cholangiocarcinoma: The LITALHICA Protocol ovid.com/jnls/transplantjour…

Mesopancreas excision ✂️ International consensus 🗺️ Defined as retropancreatic compartment of lymphatic neurovascular and adipose tissue 👍 Both artery- and mesenteric-first approach OK 🧼 Total excision more curative?! to be investigated further authors.elsevier.com/c/1nQPh…

Thank you @BjsOpen for featuring our paper!!!

The @EurPancClub in 🇹🇷 has been a 💥 🥇Solid rappresentation of @HPDsurgery with both doctors and nurses as invited speakers 🇮🇹 Italy won the bid for 2030 in Milan 💪We salute @lelecapurso stepping down from secretary who did an amazing job

Live from @ILLS_LAPLIVER 2026 in Malaga 🇪🇸 such a great time with colleagues and friends from all over the world Hot topics 🔥 included the minimally invasive techniques for intra hepatic and perihilar cholangiocarcinoma with robot being on the rise! Keep up the good work 💪

New paper out on @AnnSurgOncol 💪💪💪